| Emily Lock, OTD, OTR/L | |
|
3201 Sw Regency Pkwy Ste 5, Bentonville, AR 72712-7488 | |
| (479) 252-3321 | |
| Not Available |
| Full Name | Emily Lock |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 3201 Sw Regency Pkwy Ste 5, Bentonville, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861117178 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OTR3710 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Emily Lock, OTD, OTR/L 3201 Sw Regency Pkwy Ste 5, Bentonville, AR 72712-7488 Ph: (479) 252-3321 | Emily Lock, OTD, OTR/L 3201 Sw Regency Pkwy Ste 5, Bentonville, AR 72712-7488 Ph: (479) 252-3321 |
News Archive
MMI-USA, a subsidiary of Memometal Technologies S.A., a global orthopaedic manufacturer headquartered in France, announces the limited launch of the new Smart Toe® II Hammertoe Fixation System. The product becomes an important piece of a comprehensive system for forefoot fixation, and reinforces the most widely used franchise of intramedullary implants of this kind in the world.
In a study published on line this week in the journal Human Molecular Genetics, Drs. Donita Garland, Rosario Fernandez-Godino, and Eric Pierce of the Ocular Genomics Institute at the Massachusetts Eye and Ear, Harvard Medical School, along with their colleagues, reported the unexpected finding that in mice genetically engineered to have an inherited form of macular degeneration, turning off the animals' complement system, a part of the immune system, prevented the disease.
A new genetic substudy of PLATO showed that the effects on a combined primary endpoint of cardiovascular death, myocardial infarction, or stroke seen in Acute Coronary Syndromes patients who received the investigational oral antiplatelet treatment, ticagrelor (BRILINTA), were maintained, whether or not they had the genetic variability that has been previously shown to affect a patient's response to clopidogrel.
The Max Planck Society (Max-Planck-Gesellschaft), Germany's leading basic research organization, announced today that it has signed with Fovea Pharmaceuticals, the Ophthalmology Division of Sanofi, a research collaboration and license agreement to identify and develop innovative solutions for restoring vision in patients suffering from diseases affecting the retina.
› Verified 9 days ago
Tabitha Dawn Cooper, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1601 Greenhouse Rd, Bentonville, AR 72713 Phone: 479-795-1260 Fax: 479-795-1261 | |
Mrs. Callie Antuna, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 500 Tiger Blvd, Bentonville, AR 72712 Phone: 479-254-5065 | |
Dr. Olivia Claire Brown, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1601 Greenhouse Rd, Bentonville, AR 72713 Phone: 479-795-1260 | |
Mr. Kevin Timothy Lucas, OTRL Occupational Therapist Medicare: Medicare Enrolled Practice Location: 3102 Nw Alberta, Bentonville, AR 72712 Phone: 479-685-3404 | |
Maggie B Grymes, OTD Occupational Therapist Medicare: Medicare Enrolled Practice Location: 3201 Sw Regency Pkwy Ste 5, Bentonville, AR 72712 Phone: 479-252-3321 | |
Molly Mcgehee, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2713 Se I St Ste 5, Bentonville, AR 72712 Phone: 479-250-4355 Fax: 479-250-4355 | |
Lauren Vavra, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 500 Tiger Blvd, Bentonville, AR 72712 Phone: 501-317-7880 |